PROM1 and adenocarcinoma: The expression of CD133 in Dukes’ stage C and D or TNM stage III and IV was evidently higher compared with that in Dukes’ stage A and B or TNM stage I and II adenocarcinomas (χ2=4.92; P<0.05; Fig. 2).